창상 이미징 기기 시장 규모, 점유율 및 동향 분석 보고서 : 제품 유형별, 기술/모달리티별, 창상 유형별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Wound Imaging Device Market Summary

The global wound imaging device market size was valued at USD 288.2 million in 2025 and is projected to grow from USD 330.2 million in 2026 to USD 953.7 million by 2033, at a CAGR of 16.4% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 47.1% in 2025. The growth of the wound imaging device industry is primarily driven by the rising prevalence of chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, along with the increasing global burden of diabetes and an aging population.

Growing adoption of AI-enabled wound assessment, digital wound documentation, and telemedicine solutions is further accelerating demand by enabling accurate wound measurement, early detection of complications, and improved clinical decision-making across healthcare settings. The increasing prevalence of chronic wounds, particularly diabetic foot ulcers (DFUs), pressure ulcers, and venous leg ulcers, is a major driver of the wound imaging device market.

As the global diabetic population continues to grow, healthcare providers are adopting wound imaging technologies to enable accurate wound measurement, monitor healing progression, and support early detection of complications. Studies indicate that people with diabetes have a 19-34% lifetime risk of developing a diabetic foot ulcer, highlighting the need for advanced wound assessment solutions.

The increasing adoption of AI-powered wound assessment technologies is a key driver of the wound imaging device market, enabling automated wound measurement, tissue classification, healing prediction, and early detection of complications with greater accuracy than conventional assessment methods. AI-based image analysis also standardizes wound documentation, reduces clinician variability, and supports remote monitoring through telemedicine, improving clinical outcomes and workflow efficiency. For instance, Swift Medical's Swift Skin & Wound platform leverages AI and a database of more than 32 million wound images to provide automated wound assessment, tissue analytics, and clinical decision support. The platform has demonstrated improved clinical efficiency, including 79% faster wound assessments and 15% fewer wound-related hospitalizations, highlighting the growing adoption of AI in wound care.

Global Wound Imaging Device Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global wound imaging device market report based on product type, technology / modality, wound type, end use, and region:

• Product Type Outlook (Revenue, USD Million, 2021 - 2033)
• Dedicated Handheld & Portable Devices
• Mobile App & Software Solutions
• Cart-based & Desktop Systems
• Technology / Modality Outlook (Revenue, USD Million, 2021 - 2033)
• Visible Light Imaging (2D/Color)
• Structured Light / 3D Volumetric Imaging
• Fluorescence Imaging
• Near-Infrared (NIR) & Hyperspectral Imaging
• Thermal Imaging
• Wound Type Outlook (Revenue, USD Million, 2021 - 2033)
• Chronic Wounds
  • Diabetic Foot Ulcers (DFUs)
  • Pressure Ulcers (PUs)
  • Venous Leg Ulcers (VLUs)
• Acute & Other Wounds
  • Surgical Wounds
  • Clean & Clean-Contaminated Wounds (Class I/II)
  • Contaminated & Dirty Wounds (Class III/IV)
  • Traumatic Wounds
  • Burns
• End Use Outlook (Revenue, USD Million; 2021 - 2033)
• Hospitals
• Specialized Wound Care Clinics
• Long-Term Care Facilities (Nursing Homes/Skilled Nursing)
• Home Healthcare Settings
• Research & Military Healthcare Facilities
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product Type
  • 1.1.2. Technology / Modality
  • 1.1.3. Wound Type
  • 1.1.4. End Use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Wound Imaging Device Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of chronic wounds and diabetes
    • 3.2.1.2. Growing adoption of AI-powered wound assessment technologies
    • 3.2.1.3. Increasing demand for objective and standardized wound measurement
    • 3.2.1.4. Expansion of telemedicine and remote wound monitoring
    • 3.2.1.5. Technological advancements in 3d, fluorescence, and hyperspectral imaging
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced wound imaging devices
    • 3.2.2.2. Limited reimbursement for digital wound imaging solutions
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Expansion of AI-enabled clinical decision support systems
    • 3.2.3.2. Growing adoption of home healthcare and remote patient monitoring
    • 3.2.3.3. Increasing integration with electronic health records (EHRs)
    • 3.2.3.4. Rising demand for smartphone-based wound imaging applications
    • 3.2.3.5. Expansion into emerging healthcare markets
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Lack of standardized wound imaging and assessment protocols
    • 3.2.4.2. Variability in image quality across different devices
• 3.3. Wound Imaging Device Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Wound Imaging Device Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Wound Imaging Device Market Product Type Movement Analysis
• 4.3. Global Wound Imaging Device Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
• 4.4. Dedicated Handheld & Portable Devices
  • 4.4.1. Dedicated handheld & portable devices market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Mobile App & Software Solutions
  • 4.5.1. Mobile app & software solutions market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.6. Cart-based & Desktop Systems
  • 4.6.1. Cart-based & desktop systems market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Wound Imaging Device Market: Technology / Modality Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Wound Imaging Device Market Technology / Modality Movement Analysis
• 5.3. Global Wound Imaging Device Market Size & Trend Analysis, by Technology / Modality, 2021 to 2033 (USD Million)
• 5.4. Visible Light Imaging (2D/Color)
  • 5.4.1. Visible light imaging (2D/Color) market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.5. Structured Light / 3D Volumetric Imaging
  • 5.5.1. Structured light / 3D volumetric imaging market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.6. Fluorescence imaging
  • 5.6.1. Fluorescence imaging market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.7. Near-Infrared (NIR) & Hyperspectral Imaging
  • 5.7.1. Near-infrared (NIR) & hyperspectral imaging market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.8. Thermal Imaging
  • 5.8.1. Thermal imaging market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Wound Imaging Device Market: Wound Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Wound Imaging Device Market Wound Type Movement Analysis
• 6.3. Global Wound Imaging Device Market Size & Trend Analysis, by Wound Type, 2021 to 2033 (USD Million)
• 6.4. Chronic Wounds
  • 6.4.1. Chronic wounds market estimates and forecasts for 2021 to 2033 (USD Million)
  • 6.4.2. Diabetic Foot Ulcers (DFUs)
    • 6.4.2.1. Diabetic foot ulcers (DFUs) market estimates and forecasts for 2021 to 2033 (USD Million)
  • 6.4.3. Pressure Ulcers (PUs)
    • 6.4.3.1. Pressure ulcers (PUs) market estimates and forecasts for 2021 to 2033 (USD Million)
  • 6.4.4. Venous Leg Ulcers (VLUs)
    • 6.4.4.1. Venous leg ulcers (VLUs) market estimates and forecasts for 2021 to 2033 (USD Million)
• 6.5. Acute & Other Wounds
  • 6.5.1. Acute & Other Wounds market estimates and forecasts for 2021 to 2033 (USD Million)
  • 6.5.2. Surgical Wounds
    • 6.5.2.1. Surgical Wounds market estimates and forecasts for 2021 to 2033 (USD Million)
    • 6.5.2.2. Clean & Clean-Contaminated Wounds (Class I/II)
      • 6.5.2.2.1. Clean & Clean-Contaminated Wounds (Class I/II) market estimates and forecasts for 2021 to 2033 (USD Million)
    • 6.5.2.3. Contaminated & Dirty Wounds (Class III/IV)
      • 6.5.2.3.1. Contaminated & Dirty Wounds (Class III/IV) market estimates and forecasts for 2021 to 2033 (USD Million)
  • 6.5.3. Burns
    • 6.5.3.1. Burns market estimates and forecasts for 2021 to 2033 (USD Million)
  • 6.5.4. Traumatic Wounds
    • 6.5.4.1. Traumatic Wounds market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 7. Wound Imaging Device Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Wound Imaging Device Market End Use Movement Analysis
• 7.3. Global Wound Imaging Device Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.5. Specialized Wound Care Clinics
  • 7.5.1. Specialized wound care clinics market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.6. Long-Term Care Facilities (Nursing Homes/Skilled Nursing)
  • 7.6.1. Long-term care facilities (nursing homes/skilled nursing) market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.7. Home Healthcare Settings
  • 7.7.1. Home healthcare settings market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.8. Research & Military Healthcare Facilities
  • 7.8.1. Research & military healthcare facilities market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 8. Wound Imaging Device Market: Regional Estimates & Trend Analysis by Product Type, Wound Type, Technology / Modality, and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. Reimbursement scenario
    • 8.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Reimbursement scenario
    • 8.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory framework
    • 8.3.4.4. Reimbursement scenario
    • 8.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Competitive scenario
    • 8.4.1.3. Regulatory framework
    • 8.4.1.4. Reimbursement scenario
    • 8.4.1.5. UK market estimates and forecasts, 2021 - 2033
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. Germany market estimates and forecasts, 2021 - 2033
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. France market estimates and forecasts, 2021 - 2033
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Reimbursement scenario
    • 8.4.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 8.4.6. Denmark
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Regulatory framework
    • 8.4.6.4. Reimbursement scenario
    • 8.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Reimbursement scenario
    • 8.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 8.4.8. Norway
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Reimbursement scenario
    • 8.4.8.5. Norway market estimates and forecasts, 2021 - 2033
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement scenario
    • 8.5.1.5. Japan market estimates and forecasts, 2021 - 2033
  • 8.5.2. India
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. India market estimates and forecasts, 2021 - 2033
  • 8.5.3. China
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. China market estimates and forecasts, 2021 - 2033
  • 8.5.4. South Korea
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
  • 8.5.5. Australia
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. Australia market estimates and forecasts, 2021 - 2033
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement scenario
    • 8.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement scenario
    • 8.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Innovators
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. MolecuLight
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. Spectral AI, Inc.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Swift Medical Inc.
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. eKare, Inc.
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Net Health
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Kent Imaging Inc.
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. WoundVision
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Adiuvo Diagnostics Private Limited
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. ARANZ Medical Limited
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. WoundZoom
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. Healthy.io Ltd
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. imito AG
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Product benchmarking
    • 9.3.14.4. Strategic initiatives
• 9.4. Estimated Company Market Share Analysis, 2025
• 9.5. List of Other Key Market Players